Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387313670> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- W4387313670 abstract "We characterize the geographic distribution of providers trained to inject Clostridium histolyticum and identify areas with low provider availability.We utilized a publicly available search tool to identify clinical sites offering Clostridium histolyticum in the U.S. The data gathered included the provider's name, specialty, address, and whether the site was considered high-volume (ie, administer ≥20 Clostridium histolyticum injections per year). Data were compared to the AUA Census.In total, 2,388 clinical sites offering Clostridium histolyticum were identified. A total of 894 sites (37%) were high-volume sites. The mean number of locations offering Clostridium histolyticum per 100,000 state residents was 0.69 (SD 0.27). Georgia (1.28), Rhode Island (1.13), and Alaska (1.10) had the highest number, whereas New Mexico (0.10), Maine (0.22), and Delaware (0.30) had the lowest. The mean proportion of urologists providing Clostridium histolyticum to total urologists was 0.17 (SD 0.07). The 3 states with the highest proportion were Georgia (0.37), Alaska (0.31), and Utah (0.30), whereas New Mexico (0.03), Maine (0.05), and Vermont (0.06) had the lowest.States with low numbers of clinical sites offering Clostridium histolyticum per 100,000 residents relative to other states also had a low total ratio of urologists offering Clostridium histolyticum as a treatment. There is room for urologists in these states and others to expand their practice to offer Clostridium histolyticum and improve patient access to this important nonsurgical treatment option." @default.
- W4387313670 created "2023-10-04" @default.
- W4387313670 creator A5033189699 @default.
- W4387313670 creator A5048136956 @default.
- W4387313670 creator A5051775695 @default.
- W4387313670 creator A5067886311 @default.
- W4387313670 creator A5072279537 @default.
- W4387313670 creator A5085863366 @default.
- W4387313670 date "2023-09-07" @default.
- W4387313670 modified "2023-10-05" @default.
- W4387313670 title "Significant Geographic Variation in Access to Certified Collagenase <i>Clostridium histolyticum</i> Injectors for Peyronie’s Disease Throughout the United States" @default.
- W4387313670 doi "https://doi.org/10.1097/upj.0000000000000456" @default.
- W4387313670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37788391" @default.
- W4387313670 hasPublicationYear "2023" @default.
- W4387313670 type Work @default.
- W4387313670 citedByCount "0" @default.
- W4387313670 crossrefType "journal-article" @default.
- W4387313670 hasAuthorship W4387313670A5033189699 @default.
- W4387313670 hasAuthorship W4387313670A5048136956 @default.
- W4387313670 hasAuthorship W4387313670A5051775695 @default.
- W4387313670 hasAuthorship W4387313670A5067886311 @default.
- W4387313670 hasAuthorship W4387313670A5072279537 @default.
- W4387313670 hasAuthorship W4387313670A5085863366 @default.
- W4387313670 hasConcept C126322002 @default.
- W4387313670 hasConcept C71924100 @default.
- W4387313670 hasConceptScore W4387313670C126322002 @default.
- W4387313670 hasConceptScore W4387313670C71924100 @default.
- W4387313670 hasLocation W43873136701 @default.
- W4387313670 hasLocation W43873136702 @default.
- W4387313670 hasOpenAccess W4387313670 @default.
- W4387313670 hasPrimaryLocation W43873136701 @default.
- W4387313670 hasRelatedWork W1506200166 @default.
- W4387313670 hasRelatedWork W1995515455 @default.
- W4387313670 hasRelatedWork W2048182022 @default.
- W4387313670 hasRelatedWork W2080531066 @default.
- W4387313670 hasRelatedWork W2604872355 @default.
- W4387313670 hasRelatedWork W2748952813 @default.
- W4387313670 hasRelatedWork W2899084033 @default.
- W4387313670 hasRelatedWork W3031052312 @default.
- W4387313670 hasRelatedWork W3032375762 @default.
- W4387313670 hasRelatedWork W3108674512 @default.
- W4387313670 isParatext "false" @default.
- W4387313670 isRetracted "false" @default.
- W4387313670 workType "article" @default.